Latest Articles
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer TipRanks
Published: Aug. 7, 2025, 4:18 p.m.
Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions - EurekAlert!
Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions EurekAlert!
Published: Aug. 7, 2025, 3:02 p.m.
Immunotherapy plus chemotherapy approved for endometrial cancer - The Pharmaceutical Journal
Immunotherapy plus chemotherapy approved for endometrial cancer The Pharmaceutical Journal
Published: Aug. 7, 2025, 2:48 p.m.
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes
NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes
Published: Aug. 7, 2025, 9:15 a.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers
Published: Aug. 7, 2025, 7:56 a.m.
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers - APN News
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers APN News
Published: Aug. 7, 2025, 5:45 a.m.
Cervical endometriosis mimicking cervical adenocarcinoma: A case report.
Cervical endometriosis is a rare benign condition characterized by ectopic endometrial glands and stroma within the cervix. Its clinical and imaging features resemble those of cervical adenocarcinoma, making preoperative diagnosis …
Published: Aug. 7, 2025, midnight
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers - The ASCO Post
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers The ASCO Post
Published: Aug. 6, 2025, 3:38 p.m.
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database - Frontiers
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database Frontiers
Published: Aug. 6, 2025, 2:27 p.m.
NICE approves first immunotherapy combination for endometrial cancer - Wired Gov
NICE approves first immunotherapy combination for endometrial cancer Wired Gov
Published: Aug. 6, 2025, 1:13 p.m.
Link copied to clipboard!